Barbara Santa Cruz
Physician Assistant · Rancho Cucamonga, CANPI 1881775088
Payments from drug & device makers
Across 332 payments — averaging $21.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- AbbVie$780
- Lilly USA, LLC$684
- AstraZeneca$593
- Novo Nordisk$480
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$419
- plus $2K from 24 others
What the payments were for
- Food & beverage$6,95599%
- Education$941%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 66 | $1,764 |
| AbbVie | 58 | $780 |
| Lilly USA, LLC | 37 | $684 |
| AstraZeneca | 22 | $593 |
| Novo Nordisk | 16 | $480 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $419 |
| Boehringer Ingelheim | 17 | $334 |
| Pfizer | 15 | $308 |
| GSK | 14 | $303 |
| Astellas Pharma US Inc | 9 | $278 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $179 |
| Amgen(2 entities) | 10 | $169 |
| Biohaven Pharmaceuticals, Inc. | 7 | $115 |
| Johnson & Johnson | 5 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 2 | $59 |
| Mayne Pharma Commercial LLC | 2 | $51 |
| Merck | 2 | $43 |
| Dexcom, Inc. | 2 | $42 |
| Exact Sciences | 2 | $40 |
| Eisai Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Tonix Medicines, Inc. | 1 | $31 |
| Ardelyx, Inc. | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $29 |
| Amarin Pharma, Inc. | 1 | $24 |
| Bayer | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$529
- FARXIGA$274
- AIRSUPRA$274
- TRULANCE$125
- Wegovy$122
- NURTEC ODT$119
- FreeStyle Libre 2$118
How this compares
$7,049 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 89 | $87,943 |
| EliquisApixaban | 74 | $80,079 |
| FarxigaDapagliflozin Propanediol | 87 | $57,164 |
| Xigduo XrDapaglifloz Propaned/Metformin | 99 | $56,979 |
| JardianceEmpagliflozin | 34 | $42,214 |
| TrulicityDulaglutide | 28 | $31,568 |
| JanuviaSitagliptin Phosphate | 24 | $26,236 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $23,600 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 35 | $21,685 |
| MyrbetriqMirabegron | 19 | $11,977 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 12 | $10,457 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $10,365 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $7,944 |
| MovantikNaloxegol Oxalate | 14 | $5,949 |
| TradjentaLinagliptin | 11 | $5,675 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $480 | $87,94389 claims |
| PfizerEliquis | $308 | $80,07974 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $334 | $58,34657 claims |
| AstraZenecaFarxiga | $593 | $57,16487 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $303 | $53,22987 claims |
| Lilly USA, LLCTrulicity | $684 | $31,56828 claims |
| MerckJanuvia | $43 | $26,23624 claims |
| Astellas Pharma US IncMyrbetriq | $278 | $11,97719 claims |
| AbbVieSynthroid | $780 | $3,13435 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Rancho Cucamonga
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.